Description
The vaccine market is poised for a rather substantial increase in the next five years due to the number of vaccines in development and the push for a COVID-19 vaccine. As the COVID-19 outbreak advanced worldwide, companies stepped up to the challenge, scrambling to provide a potential vaccine. In addition to discussion of COVID-19 vaccine development as it stands currently, this report examines the market for human vaccines used to prevent various types of disease, focusing on commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable, with a discussion of the demanding tasks that are facing vaccine manufacturers. Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline provides the following market data:
- Worldwide Vaccine Market Revenues, 2019-2024
- Global Vaccine Market Analysis by Country, 2019 (US, EU, Japan, China, India, RoW)
- Major Manufacturers’ Shares of the World Vaccine Market, 2019
This report examines the current global market for vaccines, including discussion of prevailing issues:
- COVID-19 Vaccine Candidates
- Developing World WHO Vaccine Candidates
- Other Future Vaccine Products
- Challenges to Vaccine Development
Vaccination has played an enormous role in the prevention of disease, having had the greatest impact on human health of any medical intervention to date. As a result, vaccine-preventable diseases and their resulting deaths are now relatively rare in the developed world. However, developing nations have not benefited as much from the introduction of vaccines. Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline outlines the issues and trends affecting the vaccine industry, including:
- Increasing Life Expectancy
- Manufacturing Incentives
- Synthetic Vaccines
- Artificial Intelligence Development
- Pipeline and COVID-19 Development
The report also reviews the history and lines of business, strategic alliances and vaccine products of market participants:
- Advaxis, Inc.
- Bavarian Nordic, A/S
- Bharat Biotech International Ltd.
- CSL Limited/Seqiris
- Emergent BioSolutions, Inc.
- GlaxoSmithKline, Inc. (GSK)
- Gradalis, Inc.
- Hawaii Biotech, Inc.
- Immune Response Biopharma, Inc.
- Inovio, Inc.
- Johnson & Johnson (J&J)/Crucell/Janssen
- Medicago, Inc.
- Merck, Inc.
- Mitsubishi Tanabe Pharma Corporation
- Moderna, Inc
- Northwest Biotherapeutics, Inc.
- NovaVax, Inc.
- Pfizer, Inc.
- Sanofi Pasteur
- Serum Institute, Inc.
- Soligenix, Inc.
- SOTIO a.s.
- Takeda Pharmaceutical Co, Ltd.
- Valneva SE
Also included as an appendix is the WHO Vaccine Pipeline Tracker, a listing of WHO vaccine candidates for HIV, Ebola/Marburg, Zika, Malaria, TB and Dengue – over 400 vaccines in development.
Table of Contents
Chapter 1: Executive Summary
Overview
Scope and Methodology
COVID-19
-
- Table 1-1: Select Vaccines in Development for COVID-19
Market Overview and Potential
-
- Table 1-2: Total Worldwide Vaccine Market Revenues 2019-2024 (in billions $)
-
- Table 1-3: Global Vaccine Market Analysis by Country, 2019 (in billions USD) (US, EU, Japan, China, India, RoW)
-
- Table 1-4: Major Manufacturersí Shares of the World Vaccine Market, 2019 (%, $ Billions)
Chapter 2: Introduction to Vaccine Industry
Overview
- How Vaccines Work
- Types of Vaccines
- Table 2-1: Types of Vaccines
- Regulatory Process
Chapter 3: Production and Challenges of Vaccine Development
Vaccine Development Program
- Egg Production
- Cellular Production
Influenza Vaccine Production
Cell-based Influenza Vaccines
Manufacturing Challenges
Pandemics
- HIN1 Pandemic of 2009/2010
- Coronavirus Pandemic
Contract Manufacturing Involvement
Chapter 4: Issues and Trends of the Vaccine Industry
Overview
Increasing Life Expectancy
Manufacturing Incentives
Synthetic Vaccines
Artificial Intelligence Development
Pipeline and COVID-19 Development
-
- Table 4-1: Selected Vaccines in Development
- Phase III Vaccine Trials: Status
- Personalized Vaccines
- Table 4-2: Selected Personalized Phase 1 and 2 Vaccine Trials 2020
- COVID-19 Development
- Table 4-3: Select Vaccines in Development for COVID-19
Chapter 5: Market Participants
Advaxis, Inc.
-
- Table 5-1: Advaxis Corporate Summary
- Company Summary
- Products
Bavarian Nordic, A/S
-
- Table 5-2: Bavarian Nordic A/S Corporate Summary
- Company Summary
- Products
Bharat Biotech International Ltd.
-
- Table 5-3: Bharat Biotech Corporate Summary
- Company Summary
CSL Limited/Seqiris
-
- Table 5-4: CSL/Seqiris Corporate Summary
- Company Summary
- Products
Emergent BioSolutions, Inc.
-
- Table 5-5: Emergent BioSolutions Corporate Summary
- Company Summary
- Products
GlaxoSmithKline, Inc.
-
- Table 5-6: GlaxoSmithKline Corporate Summary
- Company Summary
- Products
- Table 5-7: GSK Marketed Vaccines 2019
Gradalis, Inc.
-
- Table 5-8: Gradalis Corporate Summary
- Company Summary
- Products
Hawaii Biotech, Inc.
-
- Table 5-9: Hawaii Biotech Corporate Summary
- Company Summary
- Products
Immune Response Biopharma, Inc.
-
- Table 5-10: Immune Response Biopharma Corporate Summary
- Company Summary
- Products
Inovio Pharmaceuticals, Inc.
-
- Table 5-11: Inovio Corporate Summary
- Company Summary
- Products
Johnson & Johnson/Crucell/Janssen
-
- Table 5-12: Johnson & Johnson Corporate Summary
- Company Summary
- Products
Medicago, Inc.
-
- Table 5-13: Medicago Corporate Summary
- Company Summary
- Products
Merck & Co, Inc.
-
- Table 5-14: Merck Corporate Summary
- Company Summary
- Products
Mitsubishi Tanabe Pharma Corporation
-
- Table 5-15: Mitsubishi Tanabe Corporate Summary
- Company Summary
- Products
Moderna, Inc
-
- Table 5-16: Moderna Corporate Summary
- Company Summary
- Products
Northwest Biotherapeutics, Inc.
-
- Table 5-17: Northwest BioTherapeutics Corporate Summary
- Company Summary
- Products
NovaVax, Inc.
-
- Table 5-18: NovaVax Corporate Summary
- Company Summary
- Products
Pfizer, Inc.
-
- Table 5-19: Pfizer Corporate Summary
- Company Summary
- Products
Sanofi Pasteur
-
- Table 5-20: Sanofi Pasteur Corporate Summary
- Company Summary
- Products
Serum Institute, Inc.
-
- Table 5-21: Serum Institute of India Corporate Summary
- Company Summary
- Products
Soligenix, Inc.
-
- Table 5-22: Soligenix Corporate Summary
- Company Summary
- Products
SOTIO a.s.
-
- Table 5-23: SOTIO Corporate Summary
- Company Summary
- Products
Takeda Pharmaceutical Co, Ltd.
-
- Table 5-24: Takeda Pharmaceutical Corporate Summary
- Company Summary
- Products
Valneva SE
-
- Table 5-25: Valneva Corporate Summary
- Company Summary
- Products
Appendix: WHO Vaccine Pipeline Tracker
-
- Table A-1: WHO Vaccine Pipeline Tracker
